
Aspira Women's Health AWH
Geschäftsbericht 2025
hinzugefügt 01.04.2026
Aspira Women's Health ROE 2011-2026 | AWH
ROE Jährlich Aspira Women's Health
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 184.36 | 510.89 | -403.65 | -104.94 | -184.23 | -174.38 | -158.99 | -308.1 | -397.87 | -108.94 | -99.76 | -32.95 | -153.12 | -171.73 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 510.89 | -403.65 | -114.53 |
ROE Vierteljährlich Aspira Women's Health
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3482.46 | 3465.02 | 575.55 | 1289.66 | 1863.02 | 2206.67 | 357.53 | 287.91 | -495.84 | -993.03 | -170.62 | -195.83 | -151.41 | -108.15 | -51.63 | -95.74 | -114.64 | -138.95 | -121.66 | -165.38 | -164.98 | -174.94 | -135.61 | -172.7 | -166.06 | -159.32 | -119.56 | -193.2 | -229.77 | -256.4 | -221.37 | -313.77 | -332.52 | -362.91 | -322.22 | -351.55 | -288.48 | -216.46 | -80.54 | -109.58 | -109.29 | -110.5 | -78.59 | -87.24 | -66.85 | -45.91 | -26.16 | -69.46 | -104.12 | -138.51 | -123.66 | -168.55 | -170.15 | -183.0 | -141.47 | -44.9 | -55.15 | -41.42 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3482.46 | -993.03 | 79.1 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Trinity Biotech plc
TRIB
|
287.88 | $ 0.65 | -1.84 % | $ 61.9 M | ||
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Agilent Technologies
A
|
22.45 | $ 115.55 | 1.0 % | $ 35.1 B | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
-227.33 | $ 1.67 | -2.34 % | $ 2.22 M | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 24.46 | 3.25 % | $ 679 M | ||
|
CareDx, Inc
CDNA
|
-7.05 | $ 21.23 | 5.83 % | $ 1.13 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
21.43 | $ 84.33 | 1.82 % | $ 5.69 B | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 16.31 | 1.75 % | $ 493 M | ||
|
Medpace Holdings
MEDP
|
98.27 | $ 410.54 | 4.35 % | $ 11.8 B | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
-4.56 | $ 169.8 | 1.23 % | $ 8.42 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
Guardant Health
GH
|
419.18 | $ 88.91 | 1.18 % | $ 11.1 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
109.89 | $ 1.98 | -2.37 % | $ 8.76 M | ||
|
Illumina
ILMN
|
-51.54 | $ 127.88 | 1.95 % | $ 20.3 B | ||
|
National Research Corporation
NRC
|
82.92 | $ 17.23 | -0.12 % | $ 386 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.97 | $ 27.47 | -0.58 % | $ 20 B | ||
|
Personalis
PSNL
|
-40.05 | $ 6.1 | 3.39 % | $ 361 M | ||
|
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-121.14 | $ 2.14 | -0.47 % | $ 4.92 M | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 102.17 | -3.92 % | $ 8.43 B | ||
|
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 263.8 | -0.43 % | $ 21.9 B | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Celcuity
CELC
|
-176.06 | $ 121.03 | 6.58 % | $ 5.66 B | ||
|
Thermo Fisher Scientific
TMO
|
12.55 | $ 469.71 | 0.64 % | $ 177 B | ||
|
NeoGenomics
NEO
|
-12.91 | $ 8.29 | 4.8 % | $ 1.06 B | ||
|
Neogen Corporation
NEOG
|
-52.72 | $ 9.54 | 2.03 % | $ 2.07 B | ||
|
Twist Bioscience Corporation
TWST
|
-16.42 | $ 60.94 | 3.55 % | $ 3.64 B | ||
|
Myriad Genetics
MYGN
|
-99.43 | $ 4.78 | -0.21 % | $ 443 M | ||
|
Natera
NTRA
|
-77.62 | $ 203.75 | 1.3 % | $ 20.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 196.27 | -1.66 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | ||
|
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | ||
|
Waters Corporation
WAT
|
25.09 | $ 309.87 | -0.43 % | $ 18.5 B |